While there are many aspects of CKD dietary therapy that are difficult in practice, I believe there are many points to ...
Phase 3 trials for three different agents show substantial reductions in kidney function decline and other improvements ...
Columbia’s Jai Radhakrishnan, MD, MS, explains how FSGS differs by phenotype and why new IgA nephropathy drugs reach so few ...
AstraZeneca today announced the US availability of ZEGFROVY® (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have ...
A central Arkansas father is fighting for his life and hoping a stranger could be the answer to his prayers as he searches ...
Sequencing of tumor tissue from 107 glioma patients reveals microbial signatures linked to tumor grade and survival, with ...
ZEGFROVY is now available in the US for post-platinum EGFR exon 20 insertion NSCLC after a 46% response rate in WU-KONG1B.
AstraZeneca (NYSE: AZN) announced the US availability of Zegfrovy (sunvozertinib), a treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth ...
Your kidneys can quietly lose most of their work before you ever feel anything is wrong, and the signs that do slip through look like ordinary daily complaints.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for ...
October 2026You were told your "kidneys are fine," but can you really rest easy?The "Creatinine" and "eGFR" columns on your ...
PANKU-Breast01: Iza-bren cut progression or death risk by 59% vs chemotherapy in pretreated HR+/HER2− advanced breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results